BioLegend is committed to supporting you with our products, resources, and technical service as you work to investigate all aspects of SARS-CoV-2 and COVID-19, including the development of novel therapeutics. This webpage is updated frequently with newly released products for the characterization of SARS-CoV-2 and the resulting host immune response, including recombinant proteins, antibodies, and multiplexing kits. In addition, you can let us know how we can best aid your research by filling out a short form.

Follow Us